AMD. Glaucoma. Two new drugs. “… unique mechanism by which it manages the cause of AMD, inhibition of migration, which is distinct from the current treatments.”

Canadian Bio Med Systems Inc, a subsidiary of ICBS Limited, has reported “… $10 million funding project for the development of two new drugs for age related macular degeneration (AMD) , and Glaucoma …” More from a Release dated November 17, sourced from Inter Canadian Business Service: Canadian Bio Med Systems, Inc. Opens $10 million funding project, for two new drugs for the treatment of eye diseases NEW YORK, MONTREAL and SAN DIEGO, CA, Nov. 17 /PRNewswire-FirstCall/ - Canadian Bio Med S

Leave a Reply

Security Code: